“Persistent Supravenous Erythematous Eruption (PSEE): A Scoping Review on an Adverse Effect Related to Docetaxel Infusion”. 2022. Research, Society and Development 11 (5): e21111527974. https://doi.org/10.33448/rsd-v11i5.27974.